Symbicort and Prasugrel drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Symbicort (budesonide; formoterol fumarate dihydrate) and Prasugrel (prasugrel). Common drug interactions include epistaxis among females and hypertension among males.

The phase IV clinical study analyzes what interactions people have when they take Symbicort and Prasugrel. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Symbicort?

Symbicort has active ingredients of budesonide; formoterol fumarate dihydrate. It is often used in asthma. eHealthMe is studying from 114,792 Symbicort users. Check the latest studies of Symbicort.

What is Prasugrel?

Prasugrel has active ingredients of prasugrel. eHealthMe is studying from 1,193 Prasugrel users. Check the latest studies of Prasugrel.



On Jul, 16, 2026

18 people who take Symbicort and Prasugrel together, and have interactions are studied.

Symbicort and Prasugrel drug interactions.

What are the common drug interactions of Symbicort and Prasugrel, by gender? *:

female:

  1. Epistaxis (bleed from the nose)
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  4. Fatigue (feeling of tiredness)
  5. Post procedural haemorrhage (post procedural bleeding)
  6. Abdominal pain
  7. Angioplasty
  8. Anxiety
  9. Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)
  10. Aortic valve incompetence

male:

  1. Hypertension (high blood pressure)
  2. Haematochezia (passage of stools containing blood)
  3. Weight decreased
  4. Acute left ventricular failure (heart attack)
  5. Acute myocardial infarction (acute heart attack)
  6. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  7. Atrioventricular block (heart block)
  8. Back pain
  9. Balance disorder
  10. Cardiac arrest

What are the common drug interactions of Symbicort and Prasugrel, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Haematochezia (passage of stools containing blood)
  2. Nausea (feeling of having an urge to vomit)
  3. Vomiting

50-59:

  1. Epistaxis (bleed from the nose)
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  4. Post procedural haemorrhage (post procedural bleeding)
  5. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  6. Burning sensation
  7. Cardiac arrest
  8. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  9. Glycosylated haemoglobin increased
  10. Hiv infection

60+:

  1. Fatigue (feeling of tiredness)
  2. Back pain
  3. Weight decreased
  4. Abdominal pain
  5. Acute left ventricular failure (heart attack)
  6. Acute myocardial infarction (acute heart attack)
  7. Angioplasty
  8. Anxiety
  9. Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)
  10. Aortic valve incompetence

What are the existing conditions these people have? *

  1. Cardiac Disorder: 3 people, 16.67%
  2. Type 2 Diabetes: 2 people, 11.11%
  3. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 11.11%
  4. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 11.11%
  5. Depression: 2 people, 11.11%
  6. Diabetes: 2 people, 11.11%
  7. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 11.11%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.56%
  9. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 1 person, 5.56%
  10. Cardiomyopathy (weakening of the heart muscle): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Symbicort and Prasugrel?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Symbicort and Prasugrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Symbicort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Prasugrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Symbicort and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prasugrel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on budesonide; formoterol fumarate dihydrate and prasugrel (the active ingredients of Symbicort and Prasugrel, respectively), and Symbicort and Prasugrel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: